A detailed history of Aquatic Capital Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 2,328 shares of HROW stock, worth $65,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,328
Holding current value
$65,370
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$33.39 - $57.5 $77,731 - $133,860
2,328 New
2,328 $78,000
Q2 2023

Aug 14, 2023

BUY
$17.37 - $28.08 $5,211 - $8,424
300 New
300 $6,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $760M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.